Healthcare Services Group Inc: Form 10-K for the period ended Dec 31, 2022
Filed with the SEC on Feb 17, 2023 and accepted by EDGAR at Feb 17, 2023, 17:28 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-01 to 2022-12-31 | $1.69bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2022-01-01 to 2022-12-31 | $1.50bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 12 months2022-01-01 to 2022-12-31 | $140.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Income tax | 12 months2022-01-01 to 2022-12-31 | $10.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-01-01 to 2022-12-31 | $34.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-01-01 to 2022-12-31 | $0.47 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | $0.47 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-01-01 to 2022-12-31 | 74,351,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-01-01 to 2022-12-31 | −$8.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-01-01 to 2022-12-31 | $5.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2022-01-01 to 2022-12-31 | $63.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2022-01-01 to 2022-12-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2022-12-31 | $508.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $718.3m | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $178.6m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2022-12-31 | $426.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000731012-23-000024. Last ingested by Listed: Oct 30, 2026, 13:40 ET. Listed shows no prices and gives no investment advice.